 | • レポートコード：MRC2012A3021 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、住血吸虫症治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。住血吸虫症治療薬の種類別市場規模（プラジカンテル、オキサムニキン、その他）、用途別市場規模（ビルハルツ住血吸虫、マンソン住血吸虫、日本住血吸虫、メコン住血吸虫、インターカラタム住血吸虫）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Shin Poong、EIPICO、Merck、Bayer、Taj Pharmaceuticals、Chandra Bhagat Pharma、 ・地域別グローバル市場分析 2015年-2020年 ・住血吸虫症治療薬の北米市場（アメリカ、カナダ、メキシコ） ・住血吸虫症治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・住血吸虫症治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・住血吸虫症治療薬の南米市場（ブラジル、アルゼンチン） ・住血吸虫症治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プラジカンテル、オキサムニキン、その他 ・用途別分析：ビルハルツ住血吸虫、マンソン住血吸虫、日本住血吸虫、メコン住血吸虫、インターカラタム住血吸虫 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Drugs for Schistosomiasis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Drugs for Schistosomiasis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.6%% in the forecast period of 2020 to 2025 and will expected to reach USD 90 million by 2025, from USD 78 million in 2019.
Market segmentation
Drugs for Schistosomiasis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drugs for Schistosomiasis market has been segmented into
Praziquantel
Oxamniquine
Other
By Application, Drugs for Schistosomiasis has been segmented into:
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drugs for Schistosomiasis market presented in the report. This section sheds light on the sales growth of different regional and country-level Drugs for Schistosomiasis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drugs for Schistosomiasis market.
The report offers in-depth assessment of the growth and other aspects of the Drugs for Schistosomiasis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Drugs for Schistosomiasis Market Share Analysis
Drugs for Schistosomiasis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drugs for Schistosomiasis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drugs for Schistosomiasis sales, revenue and market share for each player covered in this report.
The major players covered in Drugs for Schistosomiasis are:
Shin Poong
EIPICO
Merck
Bayer
Taj Pharmaceuticals
Chandra Bhagat Pharma
Among other players domestic and global, Drugs for Schistosomiasis market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Schistosomiasis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Schistosomiasis, with price, sales, revenue and global market share of Drugs for Schistosomiasis in 2018 and 2019.
Chapter 3, the Drugs for Schistosomiasis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Schistosomiasis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Drugs for Schistosomiasis market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Drugs for Schistosomiasis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Drugs for Schistosomiasis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Schistosomiasis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Schistosomiasis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Overview of Global Drugs for Schistosomiasis Market
1.4.1 Global Drugs for Schistosomiasis Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shin Poong
2.1.1 Shin Poong Details
2.1.2 Shin Poong Major Business
2.1.3 Shin Poong SWOT Analysis
2.1.4 Shin Poong Product and Services
2.1.5 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 EIPICO
2.2.1 EIPICO Details
2.2.2 EIPICO Major Business
2.2.3 EIPICO SWOT Analysis
2.2.4 EIPICO Product and Services
2.2.5 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Taj Pharmaceuticals
2.5.1 Taj Pharmaceuticals Details
2.5.2 Taj Pharmaceuticals Major Business
2.5.3 Taj Pharmaceuticals SWOT Analysis
2.5.4 Taj Pharmaceuticals Product and Services
2.5.5 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Chandra Bhagat Pharma
2.6.1 Chandra Bhagat Pharma Details
2.6.2 Chandra Bhagat Pharma Major Business
2.6.3 Chandra Bhagat Pharma Product and Services
2.6.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Drugs for Schistosomiasis Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Drugs for Schistosomiasis Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2019
3.3.2 Top 6 Drugs for Schistosomiasis Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Drugs for Schistosomiasis Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Schistosomiasis Sales and Market Share by Regions (2015-2020)
4.1.2 Global Drugs for Schistosomiasis Revenue and Market Share by Regions (2015-2020)
4.2 North America Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
4.3 Europe Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
4.5 South America Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Drugs for Schistosomiasis Sales, Revenue and Market Share by Country
5.1.1 North America Drugs for Schistosomiasis Sales and Market Share by Country (2015-2020)
5.1.2 North America Drugs for Schistosomiasis Revenue and Market Share by Country (2015-2020)
5.2 United States Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
5.3 Canada Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
5.4 Mexico Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Drugs for Schistosomiasis Sales, Revenue and Market Share by Country
6.1.1 Europe Drugs for Schistosomiasis Sales and Market Share by Country (2015-2020)
6.1.2 Europe Drugs for Schistosomiasis Revenue and Market Share by Country (2015-2020)
6.2 Germany Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
6.3 UK Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
6.4 France Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
6.5 Russia Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
6.6 Italy Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Drugs for Schistosomiasis Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Drugs for Schistosomiasis Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Drugs for Schistosomiasis Revenue and Market Share by Regions (2015-2020)
7.2 China Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
7.3 Japan Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
7.4 Korea Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
7.5 India Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
7.7 Australia Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Drugs for Schistosomiasis Sales, Revenue and Market Share by Country
8.1.1 South America Drugs for Schistosomiasis Sales and Market Share by Country (2015-2020)
8.1.2 South America Drugs for Schistosomiasis Revenue and Market Share by Country (2015-2020)
8.2 Brazil Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
8.3 Argentina Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Drugs for Schistosomiasis Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Drugs for Schistosomiasis Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Drugs for Schistosomiasis Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
9.3 Turkey Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
9.4 Egypt Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
9.5 South Africa Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Drugs for Schistosomiasis Sales and Market Share by Type (2015-2020)
10.2 Global Drugs for Schistosomiasis Revenue and Market Share by Type (2015-2020)
10.3 Global Drugs for Schistosomiasis Price by Type (2015-2020)
11 Global Drugs for Schistosomiasis Market Segment by Application
11.1 Global Drugs for Schistosomiasis Sales Market Share by Application (2015-2020)
11.2 Global Drugs for Schistosomiasis Revenue Market Share by Application (2015-2020)
11.3 Global Drugs for Schistosomiasis Price by Application (2015-2020)
12 Market Forecast
12.1 Global Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2021-2025)
12.2 Drugs for Schistosomiasis Market Forecast by Regions (2021-2025)
12.2.1 North America Drugs for Schistosomiasis Market Forecast (2021-2025)
12.2.2 Europe Drugs for Schistosomiasis Market Forecast (2021-2025)
12.2.3 Asia-Pacific Drugs for Schistosomiasis Market Forecast (2021-2025)
12.2.4 South America Drugs for Schistosomiasis Market Forecast (2021-2025)
12.2.5 Middle East & Africa Drugs for Schistosomiasis Market Forecast (2021-2025)
12.3 Drugs for Schistosomiasis Market Forecast by Type (2021-2025)
12.3.1 Global Drugs for Schistosomiasis Sales Forecast by Type (2021-2025)
12.3.2 Global Drugs for Schistosomiasis Market Share Forecast by Type (2021-2025)
12.4 Drugs for Schistosomiasis Market Forecast by Application (2021-2025)
12.4.1 Global Drugs for Schistosomiasis Sales Forecast by Application (2021-2025)
12.4.2 Global Drugs for Schistosomiasis Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Drugs for Schistosomiasis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drugs for Schistosomiasis Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Drugs for Schistosomiasis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Shin Poong Basic Information, Manufacturing Base and Competitors
Table 9. Shin Poong Drugs for Schistosomiasis Major Business
Table 10. Shin Poong Drugs for Schistosomiasis Total Revenue (USD Million) (2018-2019)
Table 11. Shin Poong SWOT Analysis
Table 12. Shin Poong Drugs for Schistosomiasis Product and Services
Table 13. Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. EIPICO Basic Information, Manufacturing Base and Competitors
Table 15. EIPICO Drugs for Schistosomiasis Major Business
Table 16. EIPICO Drugs for Schistosomiasis Total Revenue (USD Million) (2018-2019)
Table 17. EIPICO SWOT Analysis
Table 18. EIPICO Drugs for Schistosomiasis Product and Services
Table 19. EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Merck Basic Information, Manufacturing Base and Competitors
Table 21. Merck Drugs for Schistosomiasis Major Business
Table 22. Merck Drugs for Schistosomiasis Total Revenue (USD Million) (2018-2019)
Table 23. Merck SWOT Analysis
Table 24. Merck Drugs for Schistosomiasis Product and Services
Table 25. Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Bayer Basic Information, Manufacturing Base and Competitors
Table 27. Bayer Drugs for Schistosomiasis Major Business
Table 28. Bayer Drugs for Schistosomiasis Total Revenue (USD Million) (2018-2019)
Table 29. Bayer SWOT Analysis
Table 30. Bayer Drugs for Schistosomiasis Product and Services
Table 31. Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 33. Taj Pharmaceuticals Drugs for Schistosomiasis Major Business
Table 34. Taj Pharmaceuticals Drugs for Schistosomiasis Total Revenue (USD Million) (2018-2019)
Table 35. Taj Pharmaceuticals SWOT Analysis
Table 36. Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
Table 37. Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Chandra Bhagat Pharma Drugs for Schistosomiasis Major Business
Table 40. Chandra Bhagat Pharma Drugs for Schistosomiasis Total Revenue (USD Million) (2018-2019)
Table 41. Chandra Bhagat Pharma SWOT Analysis
Table 42. Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
Table 43. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Global Drugs for Schistosomiasis Sales by Manufacturer (2018-2019) (M Units)
Table 45. Global Drugs for Schistosomiasis Revenue by Manufacturer (2018-2019) (USD Million)
Table 46. Global Drugs for Schistosomiasis Sales by Regions (2015-2020) (M Units)
Table 47. Global Drugs for Schistosomiasis Sales Market Share by Regions (2015-2020)
Table 48. Global Drugs for Schistosomiasis Revenue by Regions (2015-2020) (USD Million)
Table 49. North America Drugs for Schistosomiasis Sales by Countries (2015-2020) (M Units)
Table 50. North America Drugs for Schistosomiasis Sales Market Share by Countries (2015-2020)
Table 51. North America Drugs for Schistosomiasis Revenue by Countries (2015-2020) (USD Million)
Table 52. North America Drugs for Schistosomiasis Revenue Market Share by Countries (2015-2020)
Table 53. Europe Drugs for Schistosomiasis Sales by Countries (2015-2020) (M Units)
Table 54. Europe Drugs for Schistosomiasis Sales Market Share by Countries (2015-2020)
Table 55. Europe Drugs for Schistosomiasis Revenue by Countries (2015-2020) (USD Million)
Table 56. Asia-Pacific Drugs for Schistosomiasis Sales by Regions (2015-2020) (M Units)
Table 57. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Regions (2015-2020)
Table 58. Asia-Pacific Drugs for Schistosomiasis Revenue by Regions (2015-2020) (USD Million)
Table 59. South America Drugs for Schistosomiasis Sales by Countries (2015-2020) (M Units)
Table 60. South America Drugs for Schistosomiasis Sales Market Share by Countries (2015-2020)
Table 61. South America Drugs for Schistosomiasis Revenue by Countries (2015-2020) (USD Million)
Table 62. South America Drugs for Schistosomiasis Revenue Market Share by Countries (2015-2020)
Table 63. Middle East & Africa Drugs for Schistosomiasis Sales by Countries (2015-2020) (M Units)
Table 64. Middle East & Africa Drugs for Schistosomiasis Sales Market Share by Countries (2015-2020)
Table 65. Middle East & Africa Drugs for Schistosomiasis Revenue by Countries (2015-2020) (USD Million)
Table 66. Middle East & Africa Drugs for Schistosomiasis Revenue Market Share by Countries (2015-2020)
Table 67. Global Drugs for Schistosomiasis Sales by Type (2015-2020) (M Units)
Table 68. Global Drugs for Schistosomiasis Sales Share by Type (2015-2020)
Table 69. Global Drugs for Schistosomiasis Revenue by Type (2015-2020) (USD Million)
Table 70. Global Drugs for Schistosomiasis Revenue Share by Type (2015-2020)
Table 71. Global Drugs for Schistosomiasis Sales by Application (2015-2020) (M Units)
Table 72. Global Drugs for Schistosomiasis Sales Share by Application (2015-2020)
Table 73. Global Drugs for Schistosomiasis Sales Forecast by Regions (2021-2025) (M Units)
Table 74. Global Drugs for Schistosomiasis Market Share Forecast by Regions (2021-2025)
Table 75. Global Drugs for Schistosomiasis Sales Forecast by Type (2021-2025) (M Units)
Table 76. Global Drugs for Schistosomiasis Market Share Forecast by Type (2021-2025)
Table 77. Global Drugs for Schistosomiasis Sales Forecast by Application (2021-2025)
Table 78. Global Drugs for Schistosomiasis Market Share Forecast by Application (2021-2025)
Table 79. Direct Channel Pros & Cons
Table 80. Indirect Channel Pros & Cons
Table 81. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Drugs for Schistosomiasis Picture
Figure 2. Global Sales Market Share of Drugs for Schistosomiasis by Type in 2019
Figure 3. Praziquantel Picture
Figure 4. Oxamniquine Picture
Figure 5. Other Picture
Figure 6. Drugs for Schistosomiasis Sales Market Share by Application in 2019
Figure 7. S. haematobium Picture
Figure 8. S. mansoni Picture
Figure 9. S. japonicum Picture
Figure 10. S. mekongi Picture
Figure 11. S. intercalatum Picture
Figure 12. Global Drugs for Schistosomiasis Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Drugs for Schistosomiasis Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2019
Figure 33. Global Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Drugs for Schistosomiasis Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Drugs for Schistosomiasis Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 38. Global Drugs for Schistosomiasis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Drugs for Schistosomiasis Revenue Market Share by Regions (2015-2020)
Figure 40. Global Drugs for Schistosomiasis Revenue Market Share by Regions in 2018
Figure 41. North America Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
Figure 42. Europe Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
Figure 44. South America Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Drugs for Schistosomiasis Sales and Growth Rate (2015-2020)
Figure 46. North America Drugs for Schistosomiasis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Drugs for Schistosomiasis Sales Market Share by Countries (2015-2020)
Figure 48. North America Drugs for Schistosomiasis Sales Market Share by Countries in 2018
Figure 49. North America Drugs for Schistosomiasis Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Drugs for Schistosomiasis Revenue Market Share by Countries in 2018
Figure 51. United States Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 52. Canada Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 53. Mexico Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 54. Europe Drugs for Schistosomiasis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Drugs for Schistosomiasis Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Drugs for Schistosomiasis Revenue Market Share by Countries in 2019
Figure 57. Germany Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 58. UK Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 59. France Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 60. Russia Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 61. Italy Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 62. Asia-Pacific Drugs for Schistosomiasis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Drugs for Schistosomiasis Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Drugs for Schistosomiasis Revenue Market Share by Regions 2019
Figure 65. China Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 66. Japan Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 67. Korea Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 68. India Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 69. Southeast Asia Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 70. South America Drugs for Schistosomiasis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Drugs for Schistosomiasis Sales Market Share by Countries in 2019
Figure 72. South America Drugs for Schistosomiasis Revenue Market Share by Countries in 2019
Figure 73. Brazil Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 74. Argentina Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 75. Middle East and Africa Drugs for Schistosomiasis Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 80. Egypt Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 81. Turkey Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 82. South Africa Drugs for Schistosomiasis Sales and Growth Rate (2015-2020) (M Units)
Figure 83. Global Drugs for Schistosomiasis Sales and Growth Rate (2021-2025) (M Units)
Figure 84. Global Drugs for Schistosomiasis Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Drugs for Schistosomiasis Market Forecast (2021-2025) (M Units)
Figure 86. Europe Sales Drugs for Schistosomiasis Market Forecast (2021-2025) (M Units)
Figure 87. Asia-Pacific Sales Drugs for Schistosomiasis Market Forecast (2021-2025) (M Units)
Figure 88. South America Sales Drugs for Schistosomiasis Market Forecast (2021-2025) (M Units)
Figure 89. Middle East & Africa Sales Drugs for Schistosomiasis Market Forecast (2021-2025) (M Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…- タイサブリ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri Drugs market report pro…
- イロプロスト治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Iloprost Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- テネクテプラーゼ薬の世界市場（～2026年） Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug. It is estimated that North America dominated the…
- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…